These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27401013)

  • 1. An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK.
    Fraccaro P; van der Veer S; Brown B; Prosperi M; O'Donoghue D; Collins GS; Buchan I; Peek N
    BMC Med; 2016 Jul; 14():104. PubMed ID: 27401013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
    Ali I; Donne RL; Kalra PA
    BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.
    Schroeder EB; Yang X; Thorp ML; Arnold BM; Tabano DC; Petrik AF; Smith DH; Platt RW; Johnson ES
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):87-94. PubMed ID: 28028051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk models to predict chronic kidney disease and its progression: a systematic review.
    Echouffo-Tcheugui JB; Kengne AP
    PLoS Med; 2012; 9(11):e1001344. PubMed ID: 23185136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we predict when to start renal replacement therapy in patients with chronic kidney disease using 6 months of clinical data?
    Lee MJ; Park JH; Moon YR; Jo SY; Yoon D; Park RW; Jeong JC; Park I; Shin GT; Kim H
    PLoS One; 2018; 13(10):e0204586. PubMed ID: 30286208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of six clinical models for prediction of chronic kidney disease in a German population.
    Stolpe S; Kowall B; Zwanziger D; Frank M; Jöckel KH; Erbel R; Stang A
    BMC Nephrol; 2022 Aug; 23(1):272. PubMed ID: 35915408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study.
    Xie Y; Maziarz M; Tuot DS; Chertow GM; Himmelfarb J; Hall YN
    BMC Nephrol; 2016 Jun; 17(1):57. PubMed ID: 27276913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes.
    Gurudas S; Nugawela M; Prevost AT; Sathish T; Mathur R; Rafferty JM; Blighe K; Rajalakshmi R; Mohan AR; Saravanan J; Majeed A; Mohan V; Owens DR; Robson J; Sivaprasad S;
    Sci Rep; 2021 Jul; 11(1):13654. PubMed ID: 34211028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the kidney failure risk equation in European CKD patients.
    Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis.
    Perotte A; Ranganath R; Hirsch JS; Blei D; Elhadad N
    J Am Med Inform Assoc; 2015 Jul; 22(4):872-80. PubMed ID: 25896647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of prognostic models for chronic kidney disease among type 2 diabetes.
    Saputro SA; Pattanateepapon A; Pattanaprateep O; Aekplakorn W; McKay GJ; Attia J; Thakkinstian A
    J Nephrol; 2022 Jul; 35(6):1637-1653. PubMed ID: 34997924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional observation study to investigate the impact of risk-based stratification on care pathways for patients with chronic kidney disease: protocol paper.
    Bhachu HK; Cockwell P; Subramanian A; Nirantharakumar K; Kyte D; Calvert M
    BMJ Open; 2019 Jun; 9(6):e027315. PubMed ID: 31182446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals.
    Dashtban A; Mizani MA; Pasea L; Denaxas S; Corbett R; Mamza JB; Gao H; Morris T; Hemingway H; Banerjee A
    EBioMedicine; 2023 Mar; 89():104489. PubMed ID: 36857859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction in chronic kidney disease: pitfalls and caveats.
    Rigatto C; Sood MM; Tangri N
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods.
    Collins GS; Omar O; Shanyinde M; Yu LM
    J Clin Epidemiol; 2013 Mar; 66(3):268-77. PubMed ID: 23116690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.